Abstract
Solid dispersions were prepared via a solvent evaporation method, employing ethanol (96%, v/v) as solvent, with three different polymers as carrier: povidone, copovidone, and poloxamer 407. Previously developed reversed-phase HPLC (RP-HPLC) methods were modified and used for the simultaneous determination of acetylsalicylic acid and clopidogrel bisulfate and after release from solid dispersions. Chromatography was carried out on a C-18 column, with a mobile phase of acetonitrile–methanol–phosphate buffer pH 3.0, UV detection at 240 nm, and a run time of 6 min. The method was validated according to International Conference of Harmonisation guidelines and validation included specificity, accuracy, precision, linearity, robustness, limit of detection (LOD), and limit of quantification (LOQ). The method is specific for determination of acetylsalicylic acid and clopidogrel bisulfate. The linearity was provided in the concentration range 0.0275–0.1375 mg/mL for acetylsalicylic acid and 0.0200–0.1000 mg/mL for clopidogrel bisulfate, with a correlation coefficient (R2 value) of 0.9999 for both active pharmaceutical ingredients (APIs). Accuracy was confirmed by calculated recoveries for acetylsalicylic acid (98.6–101.0%) and clopidogrel bisulfate (100.0–101.6%). The intra-day and the inter-day precision-calculated relative standard deviations are less than 1%, which indicates high precision of the method. The limits of detection and quantification for acetylsalicylic acid were 0.0004 and 0.0012 mg/mL, and for clopidogrel bisulfate 0.0002 mg/mL and 0.0007 mg/mL, respectively. Small variations in chromatographic conditions did not significantly affect qualitative and quantitative system responses, which proved robustness of method. The proposed RP-HPLC method was applied for simultaneous determination of clopidogrel bisulfate and acetylsalicylic acid from solid dispersions.
Highlights
According to the World Health Organization (WHO), ischemic heart disease and stroke is the leading cause of adult-acquired disability and death worldwide [1]
The proposed reversed-phase HPLC (RP-HPLC) method was applied for simultaneous determination of clopidogrel bisulfate and acetylsalicylic acid from solid dispersions
The method was validated for simultaneous estimation of acetylsalicylic acid and clopidogrel combinations using specificity, linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), and robustness
Summary
Several antiplatelet drugs with different mechanisms of action are currently available for secondary prevention of cardiovascular. According to the World Health Organization (WHO), ischemic heart disease and stroke is the leading cause of adult-acquired disability and death worldwide [1]. Sci. 2020, 10, 4792 of 10 different mechanisms of action are currently available for secondary prevention of cardiovascular events such as ischemic stroke, myocardial infarction, and peripheral vascular disease. The most events such as ischemic stroke, infarction, and vascular disease. The prasugrel, most used used oral antiplatelet drugsmyocardial are acetylsalicylic acid,peripheral clopidogrel, dipyridamole, oral antiplatelet drugs are acetylsalicylic acid, clopidogrel, dipyridamole, prasugrel, epoprostenol, epoprostenol, and streptokinase. A combination of clopidogrel with acetylsalicylic acid may be and streptokinase
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
